SMS Pharmaceuticals Outperforms Sector Amid Broader Market Gains and Mixed Momentum
SMS Pharmaceuticals has experienced notable activity, gaining 8.53% on March 19, 2025, and outperforming its sector. The stock has shown consecutive gains over two days, with a total return of 9.16%. In the broader market, mid-cap stocks are leading, while the Sensex remains below its 50-day moving average.
SMS Pharmaceuticals has shown significant activity today, gaining 8.53% as of March 19, 2025. This performance marks a notable outperformance against its sector, exceeding sector gains by 7.32%. The stock has been on a positive trajectory, achieving consecutive gains over the last two days, with a total return of 9.16% during this period.Intraday, SMS Pharmaceuticals reached a high of Rs 206.9, reflecting a 7.99% increase. In terms of moving averages, the stock is currently above its 5-day and 20-day moving averages, although it remains below the 50-day, 100-day, and 200-day moving averages, indicating mixed momentum in the short to medium term.
In the broader market context, the Sensex opened positively, trading at 75,545.45, up by 171.91 points or 0.32%. However, it is currently positioned below its 50-day moving average, which is also below the 200-day moving average. Mid-cap stocks are leading the market today, with the BSE Mid Cap index gaining 2.13%. Over the past year, SMS Pharmaceuticals has delivered a return of 16.18%, significantly outperforming the Sensex, which has seen a gain of 4.88%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
